For example, using an orthotopic mammary tumor model, in which grafted tumor cells were engineered to express high or low levels of tenascin-C, we observed not only more numerous TAM in tenascin-C high tumors, but that TAM were exclusively present inside “tracks” formed by tenascin-C deposition. This evidence concerns the gene TNC and neoplasm.